Company Data
Thiogenesis Therapeutics Corp.
Ticker
TTI:CA
Current Price
$0.7 -2.78%
Market Cap
$32.4M
Price Target
Refer to Report
Volume
10.0K
52wk Range
$0.51 - $0.8
Overview
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.